Mediplus has expanded its award-winning S-Cath System range for suprapubic catheterisation with the launch of S-Cath System Long, featuring longer components and enhanced features to give clinicians greater choice, flexibility, and improved usability.
The new system features an extended sheath dilator, needle, and guidewire, has been developed in response to clinician demand for longer component options in suprapubic catheterisation to meet the needs of a wider patient group.
Alongside the launch, Mediplus has also revamped the original S-Cath™ System with key upgrades, including an echogenic needle for improved ultrasound visibility, and the removal of the plastic sheath housing the guidewire to reduce plastic use. The tray layout has also been redesigned to feature numbered steps to align with the procedural sequence.
“We are proud to introduce the S-Cath System Long while also refreshing our existing range with enhancements that benefit both clinicians and patients,” said Emma Gray, Managing Director at Mediplus.
“By expanding the range and improving usability, we are giving healthcare professionals more choice to deliver safe, effective, and patient-centred care, while also honouring our commitment to the environment by reducing plastic in our packaging.”
The S-Cath System is a component kit for suprapubic catheterisation using the Seldinger technique - a safer alternative to traditional ‘blind’ suprapubic catheter insertion.
Developed in response to clinician demand for expanded options, the system builds on the assurance and efficiency of the original S-Cath, which uses the Seldinger technique for controlled suprapubic catheterisation.
Suprapubic catheters (SPCs) are associated with lower rates of catheter-associated urinary tract infections (CAUTIs) compared to urethral catheters, particularly in long-term use. They also cause less patient discomfort, reduce urethral trauma, and are linked to fewer complications such as catheter blockages and haematuria. While insertion requires clinical expertise, the S-Cath’s Seldinger-guided approach makes SPC placement more accurate and controlled.
Recognised with a Queen’s Award for Innovation, S-Cath is widely adopted by urologists and interventional radiology teams to manage acute urinary retention, one of the most common urological emergencies. Beyond acute settings, it is also used in patients with chronic conditions such as multiple sclerosis or spinal cord injury, as well as those with obstruction or uro-genital trauma.
Founded in 1986, Mediplus is a family-owned business and leading innovator in medical devices. Renowned for its dedication to quality and innovation, the company has earned two Queen’s Awards and multiple accolades for contributions to Critical Care, Pelvic Floor, and Urology. Mediplus devices are now sold in more than 40 countries worldwide.
